Strong Market Performance and Price Momentum
On 2 Jan 2026, Everest Organics Ltd surged to an intraday peak of Rs.536.4, marking its highest-ever price level. The stock opened with a notable gap up of 7.28%, reflecting strong buying interest from the outset. Throughout the trading session, it maintained upward momentum, closing with a day gain of 3.98%, significantly outperforming the Sensex, which rose by only 0.24% on the same day.
Further emphasising its strength, Everest Organics outperformed its sector by 5.99% today, highlighting its relative resilience and appeal within the Pharmaceuticals & Biotechnology industry. The stock is currently trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained bullish trend across multiple timeframes.
Impressive Short and Long-Term Returns
Everest Organics Ltd’s recent price action is part of a broader pattern of strong returns. Over the past week, the stock has gained 13.45%, vastly outpacing the Sensex’s 0.41% rise. The momentum extends over longer periods as well, with a one-month gain of 25.75% compared to the Sensex’s 0.30%, and a three-month increase of 28.09% against the benchmark’s 5.44%.
Most notably, the stock has delivered a remarkable 76.24% return over the last year, dwarfing the Sensex’s 6.81% gain. Year-to-date performance also remains positive at 2.79%, compared to the Sensex’s modest 0.20% rise. Over three years, Everest Organics has surged by an extraordinary 323.37%, far exceeding the Sensex’s 39.60% growth, illustrating its capacity for sustained value creation over the medium term.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Sector and Market Capitalisation Context
Everest Organics operates within the Pharmaceuticals & Biotechnology sector, a space characterised by innovation and steady demand. The company’s market capitalisation grade stands at 4, reflecting a mid-tier valuation within its peer group. This grading aligns with its current Mojo Score of 57.0, which has improved from a previous Sell rating to a Hold as of 20 Jun 2025, signalling a positive shift in market perception and fundamental strength.
The upgrade in Mojo Grade from Sell to Hold indicates enhanced confidence in the company’s financial health and market positioning. This improvement is a testament to Everest Organics’ ability to deliver consistent performance amid a competitive industry landscape.
Historical Performance and Comparative Analysis
While Everest Organics has demonstrated exceptional returns over the past three and five years, its ten-year performance remains at 0.00%, suggesting that the company’s significant growth trajectory is a relatively recent phenomenon. This recent acceleration contrasts with the Sensex’s 226.41% gain over the same decade, highlighting Everest Organics’ emergence as a strong contender in recent years.
Over five years, Everest Organics has posted an 83.81% return, slightly surpassing the Sensex’s 78.38%, further underscoring its growing stature in the market. This performance reflects the company’s successful execution of its business strategy and its ability to capitalise on sectoral growth trends.
Everest Organics Ltd or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Key Metrics and Market Standing
Everest Organics Ltd’s current market cap grade of 4 and Mojo Score of 57.0 place it in a Hold category, reflecting a balanced outlook based on its fundamentals and market behaviour. The stock’s ability to maintain trading above all major moving averages confirms its technical strength and investor confidence.
Its outperformance relative to the Sensex and sector benchmarks across multiple time horizons highlights the company’s consistent value creation. The recent upgrade in Mojo Grade from Sell to Hold further validates the company’s improving fundamentals and market sentiment.
Overall, Everest Organics Ltd’s achievement of a new all-time high at Rs.536.4 is a significant milestone that encapsulates years of steady growth and strategic execution within the Pharmaceuticals & Biotechnology sector.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →
